Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POU class 3 homeobox 3 (POU3F3) is a transcription factor encoded by the POU3F3 gene, which features two functional domains (POU-specific and homeobox domains) critical for sequence-specific DNA binding. It is most active during neural development, regulating cortical neuron migration, layer specification, and neurogenesis by binding to octamer motifs in the promoters/enhancers of target genes[1][3][4][5][6][7]. Pathogenic variants in POU3F3 cause Snijders Blok-Fisher Syndrome, a rare neurodevelopmental disorder marked by delayed speech, global developmental delay, intellectual disability, autistic features, epilepsy, hypotonia, dysmorphic features, and other comorbidities (e.g., hearing loss, ophthalmological anomalies, joint hypermobility)[3][8]. POU3F3 is not a direct target for therapeutic drugs but serves as a crucial developmental regulator whose dysfunction leads to a spectrum of neurodevelopmental disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POU class 3 homeobox 3 (POU3F3).